You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
AstraZeneca
Dow
Colorcon
Moodys

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Litigation Details for INTELGENX CORP. v. WOCKHARDT BIO, AG (D.N.J. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in INTELGENX CORP. v. WOCKHARDT BIO, AG
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for INTELGENX CORP. v. WOCKHARDT BIO, AG (D.N.J. 2013)

Date Filed Document No. Description Snippet Link To Document
2014-10-10 59 expiration of United States Patent No. 7,674,479 (the ‘479 patent) (the patent-in-suit) owned by IntelGenx…. 7, 674,479 (“the ‘479 patent”) related to Wockhardt’s ANDA seeking approval to market a generic version…invalidity of one or more claims of United States Patent No. 7,674,479 …Declaratory Judgment of Noninfringement of U.S. Patent No. 7,674,479) 37. Wockhardt repeats and incorporates… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Johnson and Johnson
Colorcon
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.